Literature DB >> 20171075

Myeloid-derived suppressor cell heterogeneity and subset definition.

Elisa Peranzoni1, Serena Zilio, Ilaria Marigo, Luigi Dolcetti, Paola Zanovello, Susanna Mandruzzato, Vincenzo Bronte.   

Abstract

Myeloid derived suppressor cells (MDSCs) are defined in mice on the basis of CD11b and Gr-1 marker expression and the functional ability to inhibit T lymphocyte activation. Nevertheless the term 'heterogeneous' remains the first, informal feature commonly attributed to this population. It is clear that CD11b(+)Gr-1(+) cells are part of a myeloid macropopulation, which comprises at least two subsets of polymorphonuclear and monocytic cells with different immunosuppressive properties. While recent literature shows substantial agreement on the immunoregulatory property of the monocytic MDSC subset, there is still contrasting evidence on the role of the granulocytic fraction. Moreover, this dichotomy holds true for human MDSCs. We attempt here to summarize conflicting findings in the field and provide some possible, unifying explanations. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20171075     DOI: 10.1016/j.coi.2010.01.021

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  305 in total

1.  Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.

Authors:  Baisakhi Raychaudhuri; Patricia Rayman; Joanna Ireland; Jennifer Ko; Brian Rini; Ernest C Borden; Jorge Garcia; Michael A Vogelbaum; James Finke
Journal:  Neuro Oncol       Date:  2011-06       Impact factor: 12.300

2.  The role of Gr1+ cells after anti-CD20 treatment in type 1 diabetes in nonobese diabetic mice.

Authors:  Changyun Hu; Wei Du; Xiaojun Zhang; F Susan Wong; Li Wen
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

Review 3.  Myeloid suppressor cells and immune modulation in lung cancer.

Authors:  Minu K Srivastava; Åsa Andersson; Li Zhu; Marni Harris-White; Jay M Lee; Steven Dubinett; Sherven Sharma
Journal:  Immunotherapy       Date:  2012-03       Impact factor: 4.196

Review 4.  Immune predictors of cancer progression.

Authors:  Benjamin Toh; Valerie Chew; Xilei Dai; Karen Khoo; Muly Tham; Lu-En Wai; Sandra Hubert; Sumathy Velumani; Liang Zhi; Caleb Huang; Jean-Pierre Abastado
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

5.  Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis.

Authors:  Huanfa Yi; Chunqing Guo; Xiaofei Yu; Daming Zuo; Xiang-Yang Wang
Journal:  J Immunol       Date:  2012-10-03       Impact factor: 5.422

6.  In vivo ablation of plasmacytoid dendritic cells inhibits autoimmunity through expansion of myeloid-derived suppressor cells.

Authors:  Marianna Ioannou; Themis Alissafi; Louis Boon; Dimitrios Boumpas; Panayotis Verginis
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

7.  Adoptive transfer of IFN-γ-induced M-MDSCs promotes immune tolerance to allografts through iNOS pathway.

Authors:  Fan Yang; Yang Li; Weilong Zou; Yanan Xu; Hao Wang; Wei Wang; Yong Zhao
Journal:  Inflamm Res       Date:  2019-05-04       Impact factor: 4.575

8.  Myeloid-derived suppressor cells in the development of lung cancer.

Authors:  Myrna L Ortiz; Lily Lu; Indu Ramachandran; Dmitry I Gabrilovich
Journal:  Cancer Immunol Res       Date:  2013-10-18       Impact factor: 11.151

9.  Characterization and evaluation of a new oncolytic vaccinia virus strain LIVP6.1.1 for canine cancer therapy.

Authors:  Ivaylo Gentschev; Sandeep S Patil; Marion Adelfinger; Stephanie Weibel; Ulrike Geissinger; Alexa Frentzen; Nanhai G Chen; Yong A Yu; Qian Zhang; Gregory Ogilvie; Aladar A Szalay
Journal:  Bioengineered       Date:  2012-10-23       Impact factor: 3.269

10.  C-C Chemokine Receptor Type 2-Dependent Migration of Myeloid-Derived Suppressor Cells in Protection of Islet Transplants.

Authors:  Jie Qin; Yusuke Arakawa; Miwa Morita; John J Fung; Shiguang Qian; Lina Lu
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.